European Union | BRUSSELS
Lobby Pushes for System for Pediatric Drugs
The big pharmaceutical groups want the European Union to create specific intellectual property rights for pediatric medicines. They argue that the R&D costs are the same as for adult medicines but demand is less permanent.


